v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
OPERATING ACTIVITIES:    
Net Loss $ (6,006) $ (409)
Adjustments to reconcile consolidated net loss to net cash provided by operating activities:    
Depreciation and amortization 6,598 7,466
Deferred financing cost amortization 628 479
Changes in fair value of derivative liabilities 5,507 (1,852)
Above (below) market lease amortization, net (913) (1,396)
Loss on repurchase of debt securities 700 0
Gain on preferred stock redemptions (213) 0
Unrealized loss on investment securities, net 106 0
Straight-line expense (income) (17) 8
Credit adjustments on operating lease receivables (50) 25
Net changes in assets and liabilities:    
Receivables, net 1,012 1,747
Deferred costs and other assets, net (2,252) (5,439)
Accounts payable, accrued expenses and other liabilities 134 3,058
Net cash provided by operating activities 5,234 3,687
INVESTING ACTIVITIES:    
Expenditures for real estate improvements (4,134) (4,155)
Net cash used in investing activities (4,134) (4,155)
FINANCING ACTIVITIES:    
Payments for deferred financing costs (445) 0
Dividends and distributions paid on noncontrolling interest (2,688) (2,688)
Loan proceeds 2,387 0
Loan principal payments (365) (588)
Repurchase of debt securities (1,282) 0
Net cash used in financing activities (2,393) (3,276)
DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH (1,293) (3,744)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period 39,807 55,865
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period 38,514 52,121
Supplemental Disclosure:    
Cash and cash equivalents 17,732 24,817
Restricted cash 20,782 27,304
Cash, cash equivalents, and restricted cash $ 38,514 $ 52,121

Source

HTML PDF
ZIP